1.Unilateral Parotitis and Kawasaki Disease in a Child.
Soo Young LYU ; Gil Ho BAN ; Su Eun PARK
Korean Journal of Pediatric Infectious Diseases 2014;21(3):214-218
Kawasaki disease is generally diagnosed base on its clinical features. Sometimes unusual or atypical presentations make the diagnosis of Kawasaki disease difficult. We experienced an unusual case of Kawasaki disease presented with unilateral parotitis in a 23-month old girl. Despite of intravenous antibiotics treatment, fever and unilateral parotid swelling persisted. Skin rashes, conjunctival injections, and coronary abnormalities showed up on the 8th day of fever. After the intravenous immunoglobulin and salicylates treatment, all symptoms disappeared. Although unilateral parotitis is very unusual presentation of Kawasaki disease, in case of no response to antibiotics, Kawasaki disease should be included in the differential diagnosis.
Anti-Bacterial Agents
;
Child*
;
Diagnosis
;
Diagnosis, Differential
;
Exanthema
;
Female
;
Fever
;
Humans
;
Immunoglobulins
;
Mucocutaneous Lymph Node Syndrome*
;
Parotitis*
;
Salicylates
2.Acute tubular necrosis as a part of vancomycin induced drug rash with eosinophilia and systemic symptoms syndrome with coincident postinfectious glomerulonephritis.
Kyung Min KIM ; Kyoung SUNG ; Hea Koung YANG ; Seong Heon KIM ; Hye Young KIM ; Gil Ho BAN ; Su Eun PARK ; Hyoung Doo LEE ; Su Young KIM
Korean Journal of Pediatrics 2016;59(3):145-148
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a rare and potentially fatal condition characterized by skin rash, fever, eosinophilia, and multiorgan involvement. Various drugs may be associated with this syndrome including carbamazepine, allopurinol, and sulfasalazine. Renal involvement in DRESS syndrome most commonly presents as acute kidney injury due to interstitial nephritis. An 11-year-old boy was referred to the Children's Hospital of Pusan National University because of persistent fever, rash, abdominal distension, generalized edema, lymphadenopathy, and eosinophilia. He previously received vancomycin and ceftriaxone for 10 days at another hospital. He developed acute kidney injury with nephrotic range proteinuria and hypocomplementemia. A subsequent renal biopsy indicated the presence of acute tubular necrosis (ATN) and late exudative phase of postinfectious glomerulonephritis (PIGN). Systemic symptoms and renal function improved with corticosteroid therapy after the discontinuation of vancomycin. Here, we describe a biopsy-proven case of severe ATN that manifested as a part of vancomycin-induced DRESS syndrome with coincident PIGN. It is important for clinicians to be aware of this syndrome due to its severity and potentially fatal nature.
Acute Kidney Injury
;
Allopurinol
;
Biopsy
;
Busan
;
Carbamazepine
;
Ceftriaxone
;
Child
;
Drug Hypersensitivity Syndrome
;
Edema
;
Eosinophilia*
;
Exanthema*
;
Fever
;
Glomerulonephritis*
;
Humans
;
Kidney Tubular Necrosis, Acute
;
Lymphatic Diseases
;
Male
;
Necrosis*
;
Nephritis, Interstitial
;
Proteinuria
;
Sulfasalazine
;
Vancomycin*
3.Acute tubular necrosis as a part of vancomycin induced drug rash with eosinophilia and systemic symptoms syndrome with coincident postinfectious glomerulonephritis.
Kyung Min KIM ; Kyoung SUNG ; Hea Koung YANG ; Seong Heon KIM ; Hye Young KIM ; Gil Ho BAN ; Su Eun PARK ; Hyoung Doo LEE ; Su Young KIM
Korean Journal of Pediatrics 2016;59(3):145-148
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a rare and potentially fatal condition characterized by skin rash, fever, eosinophilia, and multiorgan involvement. Various drugs may be associated with this syndrome including carbamazepine, allopurinol, and sulfasalazine. Renal involvement in DRESS syndrome most commonly presents as acute kidney injury due to interstitial nephritis. An 11-year-old boy was referred to the Children's Hospital of Pusan National University because of persistent fever, rash, abdominal distension, generalized edema, lymphadenopathy, and eosinophilia. He previously received vancomycin and ceftriaxone for 10 days at another hospital. He developed acute kidney injury with nephrotic range proteinuria and hypocomplementemia. A subsequent renal biopsy indicated the presence of acute tubular necrosis (ATN) and late exudative phase of postinfectious glomerulonephritis (PIGN). Systemic symptoms and renal function improved with corticosteroid therapy after the discontinuation of vancomycin. Here, we describe a biopsy-proven case of severe ATN that manifested as a part of vancomycin-induced DRESS syndrome with coincident PIGN. It is important for clinicians to be aware of this syndrome due to its severity and potentially fatal nature.
Acute Kidney Injury
;
Allopurinol
;
Biopsy
;
Busan
;
Carbamazepine
;
Ceftriaxone
;
Child
;
Drug Hypersensitivity Syndrome
;
Edema
;
Eosinophilia*
;
Exanthema*
;
Fever
;
Glomerulonephritis*
;
Humans
;
Kidney Tubular Necrosis, Acute
;
Lymphatic Diseases
;
Male
;
Necrosis*
;
Nephritis, Interstitial
;
Proteinuria
;
Sulfasalazine
;
Vancomycin*
4.Association with Left Ventricular Diastolic Function Parameters and Right Brachial-ankle Pulse Wave Velocity in Hemodialysis Patients.
Je LEE ; Seok Hwan KIM ; Duk Joo LEE ; Oh Wan KWON ; Jinho SHIN ; Ban Hun LEE ; Jae Ung LEE ; Soon Gil KIM ; Sang Woong HAN ; Ho Jung KIM
Korean Journal of Nephrology 2007;26(2):204-211
PURPOSE: Arterial stiffness is a major independent risk factor for cardiovascular morbidity and mortality in hemodialysis patients. It is hypothesized that arterial stiffness factor is attributable to the structural and functional changes of left ventricle (LV) caused by increased cardiac workload. So we investigated the relationship between brachial-ankle pulse wave velocity (baPWV) and diastolic dysfunction of left ventricle using echoardiographic transmitral blood flow pattern. METHODS: For 96 subjects (48 control patients, 48 hemodialysis patients), baPWV and echocardiographic indices for diastolic function, i.e. transmitral E, A, E/A, DT, IVRT were measured just before hemodialysis session. Role of baPWV was tested in a multiple regression model including age, gender, body mass index, predialysis blood pressure, heart rate, LV mass index and interdialysis weight gain. RESULTS: In the control group, LV mass index (beta=-0.350) and rbaPWV (beta=-0.403) had an independently correlation with E/A ratio. Rt-baPWV was independently correlated with DT (beta=-0.410) and IVRT (beta=0.500). In the hemodialysis group, systolic blood pressure (beta=-0.389) and heart rate (beta=-0.403) were the factors of E/A ratio. Rt-baPWV (beta=-0.557) was the factor determining E/A ratio only in female hemodialysis patients. CONCLUSION: PWV is independently correlated with E/A ratio only in female hemodialysis patients. Their relationship is limited or weak compared to normal control group.
Blood Pressure
;
Body Mass Index
;
Compliance
;
Echocardiography
;
Female
;
Fibrinogen
;
Heart Rate
;
Heart Ventricles
;
Humans
;
Mortality
;
Pulse Wave Analysis*
;
Renal Dialysis*
;
Risk Factors
;
Vascular Stiffness
;
Ventricular Function, Left
;
Weight Gain
5.Guidelines for the Use of Botulinum Toxin in Otolaryngology From the Korean Society of Laryngology, Phoniatrics and Logopedics Guideline Task Force
; Myung Jin BAN ; Chang Hwan RYU ; Joo Hyun WOO ; Young Chan LEE ; Dong Kun LEE ; Minsu KWON ; Yong Tae HONG ; Gil Joon LEE ; Hyung Kwon BYEON ; Seung Ho CHOI ; Seung Won LEE
Clinical and Experimental Otorhinolaryngology 2023;16(4):291-307
The Korean Society of Laryngology, Phoniatrics and Logopedics created a task force to establish clinical practice guidelines for the use of botulinum toxin (BT) in otolaryngology. We selected 10 disease categories: spasmodic dysphonia, essential vocal tremor, vocal fold granuloma, bilateral vocal fold paralysis, Frey’s syndrome, sialocele, sialorrhea, cricopharyngeal dysfunction, chronic sialadenitis, and first bite syndrome. To retrieve all relevant papers, we searched the CORE databases with predefined search strategies, including Medline (PubMed), Embase, the Cochrane Library, and KoreaMed. The committee reported 13 final recommendations with detailed evidence profiles. The guidelines are primarily aimed at all clinicians applying BT to the head and neck area. In addition, the guidelines aim to promote an improved understanding of the safe and effective use of BT by policymakers and counselors, as well as in patients scheduled to receive BT injections.